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INTRODUCTION
Elizabethkingia (E.) meningoseptica, formerly known asChryseobacterium meningosepticum, is an oxidase-positive, catalase-positive, non-glucose fermenting, andgram-negative bacillus that belongs to the genusChryseobacterium. Eponymously named after ElizabethKing who first described this bacterium in 1959, thisubiquitous organism has been traditionally consideredas a contaminant of blood cultures.1 Reports publishedover the past two decades have shown that thisbacterium can cause infections in both immuno-compromised and immunocompetent patients.2E. meningoseptica has been recognized as a frequentcolonizer of bile, especially following endoscopic biliarytract procedures. Although it rarely causes biliary tractinfection, cholangitis due to E. meningoseptica isgenerally associated with a favourable prognosis.3
Here, we report the case of an elderly lady whodeveloped cholangitis due to E. meningosepticafollowing biliary stent placement and died subsequentlybecause of septic shock.
CASE REPORT
A 70-year female with past history of hypertension andischemic heart disease underwent work-up for
obstructive jaundice at our hospital. She was diagnosedto have unresectable, peri-ampullary carcinoma andunderwent palliative biliary stenting. Shortly after beingdischarged from the hospital, she presented again to theemergency department with fever, abdominal pain, andshortness of breath. On physical examination, she wasfebrile, tachycardiac, tachypneic and icteric. She wasmaintaining 92% oxygen saturation on room air. Chestauscultation was notable for harsh vesicular breathingwith bilateral fine crackles.
Laboratory investigations revealed a total leukocytecount of 25.24 × 109 cells/L (reference: 4.0-11.0 × 109cells/L) with predominant neutrophilia (94.4%) andplatelet count of 575 × 109 cells/L (reference: 150-400 ×109 cells/L). Results of liver function tests includedalanine aminotransferase of 61 IU/L (reference: lessthan 36 IU/L), aspartate transaminase of 335 IU/L(reference: less than 40 IU/L), alkaline phosphatase of238 IU/L (reference: 75-120 IU/L) and total bilirubin of10.4 mg/dl (reference: 0.3-1 mg/dl) with direct andindirect bilirubin of 6.3 mg/dl and 4.1 mg/dl, respectively.
A plain chest radiograph was obtained, which revealedbilateral interstitial infiltrates. Ultrasonography of theabdomen was also performed, which revealed minimaldilatation of extra- and intra-hepatic biliary channels.Blood, urine, and sputum cultures were sent and thepatient was started empirically on clarithromycin (500mg 2×/d), metronidazole (500 mg 3×/d) and ceftriaxone(2000 mg 1×/d). However, the patient's conditionprogressively worsened and she began to developworsening respiratory failure. Arterial blood gas obtainedon supplemental oxygen revealed partial pressure ofoxygen of 51 mm Hg (reference: 70-100 mm Hg), partialpressure of carbon dioxide of 28 mm Hg (reference:36-40 mm Hg), and bicarbonate concentration of 18 mmol/L
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(reference: 22-28 mmol/L). Due to worsening tachypneaand respiratory failure, endotracheal intubation wasperformed and she was shifted to the intensive care unit.Subsequently, a central venous catheter was insertedthrough the right femoral vein.
After about 48 hours, the patient continued to havespiking fever and was started on imipenem/cilastatin(500 mg 4×/d) and vancomycin (1000 mg 2×/d).Preliminary reports of blood cultures revealed growth ofE. meningoseptica, which was disregarded as acontaminant initially. However, the patient's condition didnot improve and final reports of tracheal, blood, and urinecultures showed growth of >105 CFU/mL of E.meningoseptica. Urine culture also grew vancomycin-resistant enterococcus fecalis. E. meningoseptica wassensitive to piperacillin-tazobactam and vancomycin,while enterococcus fecalis was sensitive to linezolid.
In consultation with infectious disease specialists,antibiotic therapy with piperacillin-tazobactam (4450 mg3×/d), vancomycin (1000 mg 2×/d) and linezolid (600 mg2×/d) was instituted (on the fourth day of admission).However, the patient's condition continued to deteriorateand she developed multi-organ dysfunction. Her arterialserum lactate rose to 4.5 mmol/L (reference: 0.6-2.2mmol/L) and she began to develop hypotension (meanarterial pressure of less than 65 mm Hg). An arterialcatheter was inserted for invasive blood pressuremonitoring and norepinephrine infusion (3 mcg/minute)was started. Despite vasopressor support, patient wentinto cardiac arrest and could not be revived.
DISCUSSION
This case emphasizes the importance of consideringE. meningoseptica as a potential pathogen of the biliarytract infection. This is in contrast with previouslypublished evidence which suggested that cholangitis
with E. meningoseptica following endoscopic proceduresis associated with a good prognosis. Most strains ofE. meningoseptica are resistant to carbapenems(conferred by the metallo--lactamase, BlaB) and this isthe only bacterium known to have two chromosomally-encoded metallo--lactamase genes.4 This organism ispeculiar in that it is often sensitive to piperacillin-tazobactam, despite being resistant to carbapenem; andvancomycin has good activity against this organism,even though it is a gram-negative bacillus.5 Due to theseunique antibiotic susceptibilities, clinicians must keepE. meningoseptica in mind as a potential pathogen inpatients who develop biliary sepsis following endoscopicprocedures. A delay in recognizing this pathogen ordisregarding it as a contaminant could have disastrousconsequences for patients, as happened in the presentcase.
REFERENCES
1. Zong Z. Elizabethkingia meningoseptica as an unusualpathogen causing healthcare-associated bacteriuria. InternMed (Tokyo) 2014; 53:1877-9.
2. Ceyhan M, Yildirim I, Tekeli A, Yurdakok M, Us E, Altun B.A chryseobacterium meningosepticum outbreak observed in 3clusters involving both neonatal and non-neonatal pediatricpatients. Am J Infect Control 2008; 36:453-7.
3. Zong Z. Biliary tract infection or colonization with Elizabethkingiameningoseptica after endoscopic procedures involving thebiliary tract. Intern Med 2015; 54:11-5.
4. González LJ, Vila AJ. Carbapenem resistance inElizabethkingia meningoseptica is mediated by metallo--lactamase BlaB. Antimicrob Agents Chemother 2012; 56:1686-92.
5. Jiang X, Wang D, Wang Y, Yan H, Shi L, Zhou L. Occurrenceof antimicrobial resistance genes sul and dfrA12 in hospitalenvironmental isolates of Elizabethkingia meningoseptica.World J Microbiol Biotechnol 2012; 28:3097-3102.
Khalid Ahmed, Syeda Atia Qudsia, Abdul Rehman and Syed Hani Abidi
S36 Journal of the College of Physicians and Surgeons Pakistan 2018, Vol. 28 (Special Supplement 1 of Case Reports): S35-S36
